QPP: Protease that Prevents Apoptosis in Quiescent Cells
QPP: Protease that Prevents Apoptosis in Quiescent Cells
批准号:
6679614
负责人:
Brigitte T. Huber
金额:
$18.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1999
资助国家:
美国
项目状态:
已结题
起止时间:
1999-03-01 至 2007-12-31
关键词:
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): QPP (Quiescent cell Proline di-Peptidase), also termed DPP2/7, is a vesicular protease that cleaves dipeptides from the N-terminus of proteins, thereby impacting their half-life and/or receptor specificity. While the full functional profile of this enzyme is far from understood, in vitro experiments demonstrate that QPP is a major regulator of the G0 quiescence program in primary lymphocytes and neuronal cells. The primary objective of this renewal application is to analyze the mechanism of QPP-mediated survival in resting lymphocytes. Aim I: The most direct approach to define the functional role of QPP is to generate a mutant mouse deficient in QPP. Since previous attempts to derive conventional QP-/- mice were curbed by embryonic lethality, we propose a novel alternative to generate the mutant mouse, utilizing the Cre/IoxP recombinase system that allows conditional and inducible genome alterations. Aim II: Inhibition of QPP advances quiescent lymphocytes into cell cycle, leading to upregulation of c- Myc and p53 and finally apoptosis induction. Thus, it is postulated that QPP enzyme activity is required for maintaining the Go program. To test this hypothesis, the control of expression and mechanism of action of QPP will be delineated. Special emphasis will be given to LKLF and STAT5, two transcription factors that are implicated in positive and negative regulation of QPP expression, respectively. Furthermore, the role of c-Myc and p53 in the apoptosis pathway will be analyzed. Aim III: To fully understand the G0 survival program in eukaryotic cells, it is essential to define the physiological substrate(s) of QPP. Since this is the most ambitious project, various approaches will be used to reach this goal, including the screen of combinatorial dipeptide substrate libraries, the structural comparison of human and murine QPP with that of DPP4, and the isolation of a physiological substrate(s) by affinity matrix chromatography. Collectively, these studies will augment our limited understanding of the constitutive Go survival program in eukaryotic cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS
-
批准号:8365792
-
项目类别:
-
资助金额:$1.28万
-
财政年份:2011
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF DPP2 SUBSTRATE IN THE VMN OF THE HYPOTHALAMUS
-
批准号:8171443
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2010
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
-
批准号:7723039
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2008
-
负责人:Brigitte T. Huber
-
依托单位:
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS
-
批准号:7723069
-
项目类别:
-
资助金额:$0.52万
-
财政年份:2008
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:7366904
-
项目类别:
-
资助金额:$33.22万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:7924814
-
项目类别:
-
资助金额:$30.76万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
TARGETS FOR AUTOANTIBODIES FROM SYNOVIAL LESIONS IN CHRONIC LYME ARTHRITIS
-
批准号:7602063
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:8132466
-
项目类别:
-
资助金额:$29.53万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
-
批准号:7602033
-
项目类别:
-
资助金额:$0.86万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:7674657
-
项目类别:
-
资助金额:$31.07万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
HERV-K18 as a Risk Factor for CFIDS
-
批准号:7500307
-
项目类别:
-
资助金额:$31.03万
-
财政年份:2007
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETR
-
批准号:7369260
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2006
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
-
批准号:7369315
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2006
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETR
-
批准号:7182215
-
项目类别:
-
资助金额:$2.73万
-
财政年份:2005
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF TREATMENT-RESISTANT LYME ARTHRITIS AUTOANTIGENS
-
批准号:7182270
-
项目类别:
-
资助金额:$1.13万
-
财政年份:2005
-
负责人:Brigitte T. Huber
-
依托单位:
IDENTIFICATION OF IN VIVO SUBSTRATES OF SERINE PROTEASE QPP BY MASS SPECTROMETRY
-
批准号:6978518
-
项目类别:
-
资助金额:$2.49万
-
财政年份:2004
-
负责人:Brigitte T. Huber
-
依托单位:
Multidisciplinary Biodefense Training Program
-
批准号:7274181
-
项目类别:
-
资助金额:$11.76万
-
财政年份:2003
-
负责人:Brigitte T. Huber
-
依托单位:
Multidisciplinary Biodefense Training Program
-
批准号:6892069
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2003
-
负责人:Brigitte T. Huber
-
依托单位:
Multidisciplinary Biodefense Training Program
-
批准号:7101005
-
项目类别:
-
资助金额:$12.16万
-
财政年份:2003
-
负责人:Brigitte T. Huber
-
依托单位:
Multidisciplinary Biodefense Training Program
-
批准号:6782723
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2003
-
负责人:Brigitte T. Huber
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: